Johnson & Johnson faces uncertainty with speculation about RFK Jr. at HHS. Learn why JNJ stock remains a buy despite political risks and soft trends.

Della Rocca has taken on several CIO roles for J&J since 2019, when he became CIO for the company’s Janssen Pharmaceuticals ...

Stifel 2024 Healthcare Conference November 18, 2024 10:55 AM ETCompany ParticipantsMichael Bodner - Group President, ...